Bio-Rad Laboratories (BIO) Tax Provisions (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Tax Provisions data on file, last reported at -$162.7 million in Q1 2026.

• Quarterly Tax Provisions fell 938.66% year-over-year to -$162.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.5 million (up 109.13% YoY) and the FY2025 annual result came in at $235.6 million, up 147.28% from the prior year.
• Tax Provisions fell to -$162.7 million in Q1 2026 per BIO's latest filing, from $209.2 million in the prior quarter.
• Across five years, Tax Provisions topped out at $263.6 million in Q4 2022 and bottomed at -$1.0 billion in Q1 2022.
• The 5-year median for Tax Provisions is $15.9 million (2023), against an average of -$100.9 million.
• The widest annual swing landed in 2024, when Tax Provisions soared 575.64%; it then sank 938.66% in 2026.
• Tracing BIO's Tax Provisions over 5 years: stood at $263.6 million in 2022, then plunged by 70.16% to $78.7 million in 2023, then sank by 345.47% to -$193.1 million in 2024, then soared by 208.34% to $209.2 million in 2025, then tumbled by 177.77% to -$162.7 million in 2026.
• Per Business Quant, the three latest BIO Tax Provisions figures stand at -$162.7 million (Q1 2026), $209.2 million (Q4 2025), and -$89.2 million (Q3 2025).

Peer Comparison